Cardinal Capital Management Inc (Canada)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-15
Closed -$3K – 80
2022
Q1
$3K Buy
+15
New +$3.26K ﹤0.01% 79

Other funds holding BIIB

Cardinal Capital Management Inc (Canada)'s BIIB Position: Q2 2022 in Review

Cardinal Capital Management Inc (Canada) sold out of Biogen (BIIB) in Q2 2022, closing a stake of 15 shares — an estimated $3K sold.

Cardinal Capital Management Inc (Canada) first reported a position in BIIB in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Cardinal Capital Management Inc (Canada) reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 15 Biogen shares in Q2 2022, an estimated $3K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Biogen in Q1 2022 and held it in 1 quarter.
  • Cardinal Capital Management Inc (Canada)'s Biogen position peaked at $3K in Q1 2022.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q2 2022, filed 13 Jul 2022.